Trulieve spends another $1 million on effort to pass Florida's recreational pot amendment this fall

Trulieve has provided $55.39 million in cash and in-kind contributions to the Smart & Safe Florida political committee.

click to enlarge Trulieve spends another $1 million on effort to pass Florida's recreational pot amendment this fall
Photo via Adobe Images
The medical-cannabis company Trulieve has contributed another $1 million to a campaign to pass a constitutional amendment that would allow recreational marijuana use in Florida, according to a newly filed finance report.

In all, Trulieve has provided $55.39 million in cash and in-kind contributions to the Smart & Safe Florida political committee, which is leading efforts to pass the amendment in November.

The $1 million Trulieve contribution was almost all of the money raised by the committee during a reporting period that covered June 29 through July 5.

The committee also spent nearly $1.6 million during the period and had about $12.45 million in cash on hand, according to the report posted on the state Division of Elections website.

The initiative, which will appear on the ballot as Amendment 3, says, in part, that it would allow “adults 21 years or older to possess, purchase, or use marijuana products and marijuana accessories for non-medical personal consumption by smoking, ingestion, or otherwise.”

Voters in 2016 passed a constitutional amendment that allowed medical marijuana.

Subscribe to Creative Loafing newsletters.

Follow us: Google News | NewsBreak | Reddit | Instagram | Facebook | Twitter

WE LOVE OUR READERS!

Since 1988, CL Tampa Bay has served as the free, independent voice of Tampa Bay, and we want to keep it that way.

Becoming a CL Tampa Bay Supporter for as little as $5 a month allows us to continue offering readers access to our coverage of local news, food, nightlife, events, and culture with no paywalls.

Join today because you love us, too.

Scroll to read more Florida News articles

Join Creative Loafing Tampa Bay Newsletters

Subscribe now to get the latest news delivered right to your inbox.